Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2010, 3(3), 600-620; doi:10.3390/ph3030600
Review

Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy

*  and
Received: 26 December 2009; in revised form: 2 February 2010 / Accepted: 10 March 2010 / Published: 11 March 2010
(This article belongs to the Special Issue Cell-penetrating Peptides)
View Full-Text   |   Download PDF [444 KB, uploaded 11 March 2010]   |   Browse Figure
Abstract: Over the last couple of years, the number of original papers and reviews discussing various applications of cell penetrating peptides (CPPs) has grown exponentially. This is not remarkable since CPPs are capable of transporting the most varying cargo across cell membranes which is one of the biggest problems in drug delivery and targeted therapy. In this review, we focus on the use of CPPs and related peptides for delivery of imaging contrast agents and radionuclides to cells and tissues with the ultimate goal of in vivo molecular imaging and molecular radiotherapy of intracellular and even intranuclear targets.
Keywords: cell penetrating peptides; molecular imaging; radioimmunotherapy cell penetrating peptides; molecular imaging; radioimmunotherapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Kersemans, V.; Cornelissen, B. Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy. Pharmaceuticals 2010, 3, 600-620.

AMA Style

Kersemans V, Cornelissen B. Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy. Pharmaceuticals. 2010; 3(3):600-620.

Chicago/Turabian Style

Kersemans, Veerle; Cornelissen, Bart. 2010. "Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy." Pharmaceuticals 3, no. 3: 600-620.



Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert